Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Rev Esp Enferm Apar Dig ; 76(2): 138-43, 1989 Aug.
Article in Spanish | MEDLINE | ID: mdl-2813901

ABSTRACT

Spectral EEG analysis techniques were used to evaluate the degree of hepatic encephalopathy in a group of 69 cirrhotic patients, as compared to the results obtained in a group of healthy controls. With respect to controls, the cirrhotics had stronger delta and theta bands, and a weaker alpha band, as well as a reaction of the alpha band to opening the eyes. The use of strength ratios between different bands of frequency increments the sensitivity and diagnostic reliability of this technique, particularly the delta/alpha and theta/alpha indices, and permits the detection of cases with subclinical encephalopathy, which is particularly useful for clinical follow-up and for the evaluation of different therapeutic regimens.


Subject(s)
Electroencephalography , Hepatic Encephalopathy/physiopathology , Liver Cirrhosis/physiopathology , Adult , Aged , Alpha Rhythm , Delta Rhythm , Female , Hepatic Encephalopathy/diagnosis , Humans , Male , Middle Aged , Predictive Value of Tests , Theta Rhythm
2.
Rev Esp Enferm Apar Dig ; 75(3): 277-9, 1989 Mar.
Article in Spanish | MEDLINE | ID: mdl-2499914

ABSTRACT

We investigated the therapeutic effect of flumanezil on acute and chronic hepatic encephalopathy in a group of cirrhotics; its efficacy was evaluated using clinical data and neurophysiologic examination, e.g. brain mapping. Flumazenil was not found to induce significant changes in the clinical status or in maps of the cerebral activity of patients with chronic encephalopathy. In acute encephalopathy, flumazenil improved clinical status, as was confirmed neurophysiologically by improved cerebral activity on brain mapping.


Subject(s)
Brain Mapping , Flumazenil/therapeutic use , Hepatic Encephalopathy/drug therapy , Acute Disease , Aged , Chronic Disease , Drug Evaluation , Female , Hepatic Encephalopathy/complications , Hepatic Encephalopathy/physiopathology , Humans , Liver Cirrhosis/complications , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL